{"symbol": "CLRB", "companyName": "Cellectar Biosciences Inc.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.cellectar.com", "description": "Cellectar Biosciences Inc is a biopharmaceutical company. It is engaged in developing compounds for treatment and imaging of cancer. Its portfolio consists of PET imaging agents, optical imaging agents, and therapeutic agents.", "CEO": "James V. Caruso", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}